Publication | Open Access

Cost-Effectiveness of Antiplatelet Agents in Secondary Stroke Prevention: The Limits of Certainty

ThrombosisAntiplatelet AgentsCardiovascular DiseaseHealth PolicyIschemic StrokeMedicineStroke-related ConditionCerebrovascular DiseasePlatelet AntagonistAnticoagulantNeurologyCerebrovascular InterventionCerebral Blood FlowSecondary Stroke PreventionStrokePublic HealthAtherosclerosis